Finance Registrar Bullish on MJNA

A new article on Finance Registrar focuses on MJNA’s market cap and spotlights recent developments of its subsidiaries.

Medical Marijuana, Inc. and its subsidiary HempMeds® Brasil received high praise recently in an online article by Finance Registrar. The finance industry and investing news site spotlighted MJNA’s market cap, which it reported has surged from $180M to $343.4M.

In the piece, contributor Ross McDonald highlighted HempMeds® Brasil, whose CBD oil products were the first cannabis-based products legally authorized for import by ANVISA for patients in Brazil. Patients in Brazil can gain access to HempMeds® Brasil’s Real Scientific Hemp Oil (RSHO) pure CBD hemp oil after gaining their doctor’s prescription and authorization from ANVISA to import the products.

medical marijuana brazil

Referring to RSHO as the “go-to” cannabinoid in Brazil, McDonald detailed the publicity the company received after a young girl there used the CBD oil.

McDonald also briefly highlighted MJNA subsidiary Kannaway, a network sales and marketing company in the hemp space that has experienced 18 consecutive months of growth. He also noted the research and development of cannabinoid-based pharmaceuticals by MJNA investment companies and shared the results of a recent clinical study MJNA participated in.

MJNA a “Trailblazer”

In conclusion, the Finance Registrar piece touted that “CBD oils may end up being one of the most lucrative parts of the cannabis boom” and spotlighted Medical Marijuana, Inc. as a “trailblazer” and “truly a company to watch.”

Read the full Finance Registrar article HERE.

Discover more from HempMeds® Brasil and the Medical Marijuana, Inc. portfolio of companies on our news feed.